- Home
- CVLT vs CORT Comparison
CVLT vs CORT Comparison
Compare CVLT & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVLT | CORT |
|---|---|---|
| Founded | 1996 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.7B |
| IPO Year | 2006 | 2001 |
Fundamental Metrics
Financial Performance| Metric | CVLT | CORT |
|---|---|---|
| Price | $103.78 | $51.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 5 |
| Target Price | ★ $139.53 | $96.50 |
| AVG Volume (30 Days) | 811.4K | ★ 1.0M |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.58 | N/A |
| Revenue | ★ $1,183,690,000.00 | $761,407,000.00 |
| Revenue This Year | $13.29 | $26.08 |
| Revenue Next Year | $13.20 | $26.98 |
| P/E Ratio | $84.85 | ★ N/A |
| Revenue Growth | ★ 18.89 | 12.79 |
| 52 Week Low | $71.75 | $28.66 |
| 52 Week High | $200.68 | $91.00 |
Technical Indicators
Market Signals| Indicator | CVLT | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 63.25 | 69.84 |
| Support Level | $80.85 | $32.95 |
| Resistance Level | $129.23 | $90.00 |
| Average True Range (ATR) | 4.03 | 2.07 |
| MACD | 0.55 | 0.21 |
| Stochastic Oscillator | 86.17 | 83.30 |
Price Performance
Historical ComparisonAbout CVLT Commvault Systems Inc.
CommVault Systems Inc provides data and information management software applications and services. The firm sells software licenses and services to large global enterprises, small- and midsize businesses, and government agencies through both its salesforce and its network of reseller partners. Its software solutions include Cleanroom Recovery, HyperScale X, Air Gap Protect, Compliance, Cloud Rewind, and Clumio Backtrack. The company operates in the United States and exports to many other countries.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.